Lung-FX
Natural health product licensed in Canada
- Other names
- LUNG-FX FORMULA
- Licence holder
- Healthology Nutraceutical Inc.
- NPN or DIN-HM
- 80096884
- Status
- Active licence
- Licence date
- 29 January 2020
- Revision date
- 28 July 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Hyssopus officinalis L.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1.5 g | 150 mg | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 200 mg | Not calculated |
| Hyssopus officinalis Source : Sommité Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1 g | 100 mg | Not calculated |
| Verbascum thapsus Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2 g | 100 mg | Not calculated |
| Ganoderma lucidum Source : Corps fructifère Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1 g | 50 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Poudre d'enveloppes d'Oryza sativa (Riz), Hypromellose, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of/Provides antioxidants. Fenugreek and Hyssop are traditionally used in Herbal Medicine as an expectorant to help relieve excess mucous of the upper respiratory passages (anti-catarrhal).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if hypersensitivity/allergy occurs.
Source
Official Health Canada record, licence 80096884
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.